{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T21:12:42Z","timestamp":1761167562826,"version":"build-2065373602"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Growth Hormone & IGF Research"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1016\/j.ghir.2006.02.004","type":"journal-article","created":{"date-parts":[[2006,4,18]],"date-time":"2006-04-18T15:19:35Z","timestamp":1145373575000},"page":"119-124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Effect of alendronate on bone mineral density in adult patients with Laron syndrome (primary growth hormone insensitivity)"],"prefix":"10.1016","volume":"16","author":[{"given":"Varda","family":"Eshed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos A.","family":"Benbassat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zvi","family":"Laron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ghir.2006.02.004_bib1","first-page":"3","article-title":"Insulin-like growth factors and their bonding proteins: biological actions","volume":"16","author":"Jones","year":"1990","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ghir.2006.02.004_bib2","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/jbmr.5650050212","article-title":"Skeletal growth factor and other growth factors known to be present in bone matrix stimulate proliferation and protein synthesis in human bone cells","volume":"5","author":"Wergedal","year":"1990","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.ghir.2006.02.004_bib3","doi-asserted-by":"crossref","first-page":"44005","DOI":"10.1074\/jbc.M208265200","article-title":"Osteoblast-specific knockout of the IGF receptor gene reveals an essential role of IGF signaling in bone matrix mineralization","volume":"277","author":"Zhang","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ghir.2006.02.004_bib4","first-page":"433","article-title":"Insulin-like growth factor-1 supports formation and activation of osteoclasts","volume":"131","author":"Mochiziki","year":"1992","journal-title":"Endocrinology"},{"key":"10.1016\/j.ghir.2006.02.004_bib5","first-page":"55","article-title":"Growth hormone and bone","volume":"19","author":"Ohlsson","year":"1998","journal-title":"Endocrine Rev."},{"key":"10.1016\/j.ghir.2006.02.004_bib6","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1359\/jbmr.1998.13.8.1343","article-title":"Gender differences in IGF and bone mineral density association in old age: the Rancho Bernardo study","volume":"13","author":"Barret-Connor","year":"1998","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.ghir.2006.02.004_bib7","first-page":"4257","article-title":"Association between insulin like growth factor-I and bone mineral density in older women and men: the Framingham heart study","volume":"83","author":"Langolis","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2006.02.004_bib8","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1046\/j.1365-2265.2001.01278.x","article-title":"Low serum concentrations of insulin-like growth factor I are associated with femoral bone loss in a population-based sample of postmenopausal women","volume":"55","author":"Seck","year":"2001","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ghir.2006.02.004_bib9","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/S0140-6736(99)05463-X","article-title":"Low serum IGF-1 and occurrence of osteoporotic fractures in postmenopausal women","volume":"355","author":"Gamero","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ghir.2006.02.004_bib10","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1359\/jbmr.2001.16.12.2320","article-title":"The skeletal structure of insulin-like growth factor I-deficient mice","volume":"16","author":"Bikle","year":"2001","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.ghir.2006.02.004_bib11","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1210\/en.2002-220948","article-title":"Insulin-like growth factor regulates peak bone mineral density in mice by both growth hormone dependent and independent mechanisms","volume":"144","author":"Mohan","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.ghir.2006.02.004_bib12","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1210\/jc.2003-031033","article-title":"Laron syndrome (primary growth hormone resistance or insensitivity): the personal experience 1958\u20132003","volume":"89","author":"Laron","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2006.02.004_bib13","first-page":"269","article-title":"Growth hormone resistance","volume":"12","author":"Laron","year":"1980","journal-title":"Ann. Clin. Res."},{"key":"10.1016\/j.ghir.2006.02.004_bib14","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1365-2265.1994.tb01829.x","article-title":"IGF-1 treatment of adult patients with Laron syndrome: preliminary results","volume":"41","author":"Laron","year":"1994","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ghir.2006.02.004_bib15","unstructured":"J. Guevara-Aguirre, W. De La Torre, A. Rosenbloob, M. Acosta, R.G. Rosenfeld, Osteopenia in menstruating women with low IGF-1 levels due to growth hormone receptor deficiency, Program of the 73rd Annual Meeting of the Endocrine Society, Washington DC, 1991, p. 384."},{"key":"10.1016\/j.ghir.2006.02.004_bib16","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/jbmr.5650070204","article-title":"New approaches for interpreting projected bone densitometry data","volume":"7","author":"Carter","year":"1992","journal-title":"J. Bone Miner Res."},{"key":"10.1016\/j.ghir.2006.02.004_bib17","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1210\/jcem-73-6-1332","article-title":"Clinical and anthropometrics correlates of bone mineral acquisition in healthy adolescents","volume":"73","author":"Katzman","year":"1991","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2006.02.004_bib18","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1359\/jbmr.1998.13.3.415","article-title":"Bone mineral, histomorphometry and body composition in adults with growth hormone receptor deficiency","volume":"13","author":"Bachrach","year":"1998","journal-title":"J. Bone Miner Res."},{"key":"10.1016\/j.ghir.2006.02.004_bib19","doi-asserted-by":"crossref","first-page":"4586","DOI":"10.1210\/jc.2003-030623","article-title":"Are adult patients with Laron syndrome osteopenic? A comparison between dual-energy X-ray absorptiometry and volumetric bone densities","volume":"88","author":"Benbassat","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2006.02.004_bib20","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/j.1365-2265.1993.tb02149.x","article-title":"Effects of 17 months treatment using recombinant insulin-like growth factor-1 in two children with growth hormone insensitivity (Laron) syndrome","volume":"38","author":"Heinrichs","year":"1993","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ghir.2006.02.004_bib21","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.beem.2004.02.007","article-title":"Insulin-like growth factor I and bone mineral density: experience from animal models and human observational studies","volume":"18","author":"Rosen","year":"2004","journal-title":"Best Prac. Res. Clinl. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2006.02.004_bib22","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S8756-3282(99)00116-7","article-title":"Bisphosphonates: from the laboratory to the clinic and back again","volume":"25","author":"Russel","year":"1999","journal-title":"Bone"},{"key":"10.1016\/j.ghir.2006.02.004_bib23","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1210\/er.2001-2002","article-title":"Meta-analysis of alendronate for the treatment of postmenopausal women","volume":"23","author":"Cranney","year":"2002","journal-title":"Endocrine Rev."},{"key":"10.1016\/j.ghir.2006.02.004_bib24","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1056\/NEJM200008313430902","article-title":"Alendronate for the treatment of osteoporosis in men","volume":"343","author":"Orwell","year":"2000","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.ghir.2006.02.004_bib25","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/PL00004171","article-title":"Multinational, placebo-controlled randomized trial of the effects of alendronate on low bone density and fracture risk in postmenopausal women with low bone mass: results of the FOSIT study","volume":"9","author":"Pols","year":"1999","journal-title":"Osteoporos Int."},{"key":"10.1016\/j.ghir.2006.02.004_bib26","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1056\/NEJM199807303390502","article-title":"Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis","volume":"339","author":"Saag","year":"1998","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.ghir.2006.02.004_bib27","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S8756-3282(02)00738-X","article-title":"Effect of insulin like growth factor-1 (IGF-1) plus alendronate on bone density during puberty in IGF-1 deficient MIDI mice","volume":"30","author":"Stabnov","year":"2002","journal-title":"Bone"},{"key":"10.1016\/j.ghir.2006.02.004_bib28","doi-asserted-by":"crossref","first-page":"5759","DOI":"10.1210\/jc.2002-021654","article-title":"An investigation of the predictors of bone mineral density and response to therapy with alendronate in osteoporotic men","volume":"88","author":"Drake","year":"2003","journal-title":"J. Clin. Endorcinol. Metab."},{"key":"10.1016\/j.ghir.2006.02.004_bib29","doi-asserted-by":"crossref","unstructured":"NIH consensus development panel on osteoporosis prevention, diagnosis and therapy, JAMA 285, 2001, 785\u2013795.","DOI":"10.1001\/jama.285.6.785"},{"key":"10.1016\/j.ghir.2006.02.004_bib30","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1056\/NEJMp038101","article-title":"Periostal bone formation \u2013 a neglected determinant of bone strength","volume":"349","author":"Seeman","year":"2003","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.ghir.2006.02.004_bib31","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1136\/bmj.312.7041.1254","article-title":"Meta-analysis of how well measures of bone mineral density predicts occurrence of osteoporotic fractures","volume":"312","author":"Marshal","year":"1996","journal-title":"Br. Med. J."}],"container-title":["Growth Hormone & IGF Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637406000256?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637406000256?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T22:42:43Z","timestamp":1761086563000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096637406000256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["S1096637406000256"],"URL":"https:\/\/doi.org\/10.1016\/j.ghir.2006.02.004","relation":{},"ISSN":["1096-6374"],"issn-type":[{"type":"print","value":"1096-6374"}],"subject":[],"published":{"date-parts":[[2006,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of alendronate on bone mineral density in adult patients with Laron syndrome (primary growth hormone insensitivity)","name":"articletitle","label":"Article Title"},{"value":"Growth Hormone & IGF Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ghir.2006.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}